Generics in Japan
Generics in Japan - New Study Released
09.08.2012 12:45:57 - New Pharmaceuticals market report from MarketLine: "Generics in Japan"
(live-PR.com) - Introduction
Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan generics market. Includes market size data, textual and
graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
* For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume. All currency conversions were calculated at constant average annual 2011 exchange rates.
* The Japanese generics market had total revenues of $4,051 million in 2011, representing a compound annual growth rate (CAGR) of 5.5% between 2007 and 2011.
* Market consumption volumes increased with a CAGR of 7.3% between 2007 and 2011, to reach 22.8% of total pharma market volume in 2011.
* The performance of the market is forecast to decelerate, with an anticipated CAGR of 3.3% for the five-year period 2011 - 2016, which is expected to drive the market to a value of $4,764.8 million by the end of 2016.
------------------------------------------------------------
Full Report Details at
- www.fastmr.com/prod/447053_generics_in_japan.asp ..
------------------------------------------------------------
Features
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Japan
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Japan
Leading company profiles reveal details of key generics market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Japan generics market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Japan economy
Key Questions Answered
What was the size of the Japan generics market by value in 2011?
What will be the size of the Japan generics market in 2016?
What factors are affecting the strength of competition in the Japan generics market?
How has the market performed over the last five years?
Partial Table of Contents:
TABLE OF CONTENTS
Executive Summary
Market value
Market value forecast
Market volume
Market volume forecast
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market volume
Market Segmentation
Geography segmentation
Market Outlook
Market value forecast
Market volume forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Daiichi Sankyo Co Ltd
Nichi-iko Pharmaceutical
Sawai Pharmaceutical Co Ltd
Teva Pharmaceutical Industries
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research
LIST OF TABLES
Table 1: Japan generics market value: $ billion, 2007-11
Table 2: Japan generics market volume: % of total Pharma volume, 2007-11
Table 3: Japan generics market geography segmentation: $ billion, 2011
Table 4: Japan generics market value forecast: $ billion, 2011-16
Table 5: Japan generics market volume forecast: % of total Pharma volume, 2011-16
Table 6: Daiichi Sankyo Co Ltd: key facts
Table 7: Daiichi Sankyo Co Ltd: key financials ($)
Table 8: Daiichi Sankyo Co Ltd: key financials (JPY)
Table 9: Daiichi Sankyo Co Ltd: key financial ratios
Table 10: Nichi-iko Pharmaceutical: key facts
Table 11: Nichi-iko Pharmaceutical: key financials ($)
Table 12: Nichi-iko Pharmaceutical: key financials (JPY)
Table 13: Nichi-iko Pharmaceutical: key financial ratios
Table 14: Sawai Pharmaceutical Co Ltd: key facts
Table 15: Sawai Pharmaceutical Co Ltd: key financials ($)
Table 16: Sawai Pharmaceutical Co Ltd: key financials (JPY)
Table 17: Sawai Pharmaceutical Co Ltd: key financial ratios
Table 18: Teva Pharmaceutical Industries: key facts
Table 19: Teva Pharmaceutical Industries: key financials ($)
Table 20: Teva Pharmaceutical Industries: key financial ratios
Table 21: Japan size of population (million), 2007-11
Table 22: Japan gdp (constant 2000 prices, $ billion), 2007-11
Table 23: Japan gdp (current prices, $ billion), 2007-11
Table 24: Japan inflation, 2007-11
Table 25: Japan consumer price index (absolute), 2007-11
Table 26: Japan exchange rate, 2007-11
Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=44 ..
About MarketLine
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=103 ..
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.
Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan generics market. Includes market size data, textual and
|
|
Highlights
* For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume. All currency conversions were calculated at constant average annual 2011 exchange rates.
* The Japanese generics market had total revenues of $4,051 million in 2011, representing a compound annual growth rate (CAGR) of 5.5% between 2007 and 2011.
* Market consumption volumes increased with a CAGR of 7.3% between 2007 and 2011, to reach 22.8% of total pharma market volume in 2011.
* The performance of the market is forecast to decelerate, with an anticipated CAGR of 3.3% for the five-year period 2011 - 2016, which is expected to drive the market to a value of $4,764.8 million by the end of 2016.
------------------------------------------------------------
Full Report Details at
- www.fastmr.com/prod/447053_generics_in_japan.asp ..
------------------------------------------------------------
Features
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Japan
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Japan
Leading company profiles reveal details of key generics market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Japan generics market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Japan economy
Key Questions Answered
What was the size of the Japan generics market by value in 2011?
What will be the size of the Japan generics market in 2016?
What factors are affecting the strength of competition in the Japan generics market?
How has the market performed over the last five years?
Partial Table of Contents:
TABLE OF CONTENTS
Executive Summary
Market value
Market value forecast
Market volume
Market volume forecast
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market volume
Market Segmentation
Geography segmentation
Market Outlook
Market value forecast
Market volume forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Daiichi Sankyo Co Ltd
Nichi-iko Pharmaceutical
Sawai Pharmaceutical Co Ltd
Teva Pharmaceutical Industries
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research
LIST OF TABLES
Table 1: Japan generics market value: $ billion, 2007-11
Table 2: Japan generics market volume: % of total Pharma volume, 2007-11
Table 3: Japan generics market geography segmentation: $ billion, 2011
Table 4: Japan generics market value forecast: $ billion, 2011-16
Table 5: Japan generics market volume forecast: % of total Pharma volume, 2011-16
Table 6: Daiichi Sankyo Co Ltd: key facts
Table 7: Daiichi Sankyo Co Ltd: key financials ($)
Table 8: Daiichi Sankyo Co Ltd: key financials (JPY)
Table 9: Daiichi Sankyo Co Ltd: key financial ratios
Table 10: Nichi-iko Pharmaceutical: key facts
Table 11: Nichi-iko Pharmaceutical: key financials ($)
Table 12: Nichi-iko Pharmaceutical: key financials (JPY)
Table 13: Nichi-iko Pharmaceutical: key financial ratios
Table 14: Sawai Pharmaceutical Co Ltd: key facts
Table 15: Sawai Pharmaceutical Co Ltd: key financials ($)
Table 16: Sawai Pharmaceutical Co Ltd: key financials (JPY)
Table 17: Sawai Pharmaceutical Co Ltd: key financial ratios
Table 18: Teva Pharmaceutical Industries: key facts
Table 19: Teva Pharmaceutical Industries: key financials ($)
Table 20: Teva Pharmaceutical Industries: key financial ratios
Table 21: Japan size of population (million), 2007-11
Table 22: Japan gdp (constant 2000 prices, $ billion), 2007-11
Table 23: Japan gdp (current prices, $ billion), 2007-11
Table 24: Japan inflation, 2007-11
Table 25: Japan consumer price index (absolute), 2007-11
Table 26: Japan exchange rate, 2007-11
Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=44 ..
About MarketLine
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=103 ..
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.
| Author: |
